{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:21:46Z","timestamp":1787019706693,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-616","type":"journal-article","created":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T19:01:09Z","timestamp":1388430069000},"source":"Crossref","is-referenced-by-count":23,"title":["Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer"],"prefix":"10.1186","volume":"13","author":[{"given":"Miriam","family":"Lenhard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Heublein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Kunert-Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vrekoussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Lomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Ditsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Friese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Jeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,30]]},"reference":[{"key":"4251_CR1","volume-title":"Krebs in Deutschland 2005\/2006","author":"Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V","year":"2010","unstructured":"Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V: Krebs in Deutschland 2005\/2006. 2010, Berlin: H\u00e4ufigkeiten und Trends, 7","edition":"7"},{"key":"4251_CR2","volume-title":"Entwicklung der Pr\u00e4valenz zwischen 1900 und 2010","author":"Robert-Koch-Institut: Verbreitung von krebserkrankungen in Deutschland","year":"2010","unstructured":"Robert-Koch-Institut: Verbreitung von krebserkrankungen in Deutschland: Entwicklung der Pr\u00e4valenz zwischen 1900 und 2010. 2010, Berlin"},{"issue":"8","key":"4251_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004, 4 (8): 579-591. 10.1038\/nrc1408.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4251_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/1464727002000198781","volume":"3","author":"S Wild","year":"2000","unstructured":"Wild S, Pierpoint T, Jacobs H, McKeigue P: Long-term consequences of polycystic ovary syndrome: results of a 31\u00a0year follow-up study. Hum Fertil (Camb). 2000, 3 (2): 101-105. 10.1080\/1464727002000198781.","journal-title":"Hum Fertil (Camb)"},{"issue":"9470","key":"4251_CR5","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","volume":"365","author":"V Beral","year":"2005","unstructured":"Beral V, Bull D, Reeves G: Endometrial cancer and hormone-replacement therapy in the million women study. Lancet. 2005, 365 (9470): 1543-1551.","journal-title":"Lancet"},{"issue":"5","key":"4251_CR6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0002-9378(11)91709-8","volume":"167","author":"LA Brinton","year":"1992","unstructured":"Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L, Hoover RN: Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case\u2013control study. Am J Obstet Gynecol. 1992, 167 (5): 1317-1325. 10.1016\/S0002-9378(11)91709-8.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"4251_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1008946825313","volume":"11","author":"E Weiderpass","year":"2000","unstructured":"Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA: Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control. 2000, 11 (2): 185-192. 10.1023\/A:1008946825313.","journal-title":"Cancer Causes Control"},{"issue":"2","key":"4251_CR8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ijc.25050","volume":"127","author":"L Dossus","year":"2010","unstructured":"Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Fournier A, et al: Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010, 127 (2): 442-451.","journal-title":"Int J Cancer"},{"issue":"5","key":"4251_CR9","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1210\/jcem-52-5-1006","volume":"52","author":"JE Mazurkiewicz","year":"1981","unstructured":"Mazurkiewicz JE, Bank JF, Joshi SG: Immunocytochemical localization of a progestagen-associated endometrial protein in the human decidua. J Clin Endocrinol Metab. 1981, 52 (5): 1006-1008. 10.1210\/jcem-52-5-1006.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4251_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1095\/biolreprod25.3.591","volume":"25","author":"SG Joshi","year":"1981","unstructured":"Joshi SG, Szarowski DH, Bank JF: Decidua-associated antigens in the baboon. Biol Reprod. 1981, 25 (3): 591-598. 10.1095\/biolreprod25.3.591.","journal-title":"Biol Reprod"},{"issue":"50","key":"4251_CR11","doi-asserted-by":"publisher","first-page":"32159","DOI":"10.1074\/jbc.271.50.32159","volume":"271","author":"HR Morris","year":"1996","unstructured":"Morris HR, Dell A, Easton RL, Panico M, Koistinen H, Koistinen R, Oehninger S, Patankar MS, Seppala M, Clark GF: Gender-specific glycosylation of human glycodelin affects its contraceptive activity. J Biol Chem. 1996, 271 (50): 32159-32167. 10.1074\/jbc.271.50.32159.","journal-title":"J Biol Chem"},{"issue":"11","key":"4251_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1471-0528.1985.tb03027.x","volume":"92","author":"M Julkunen","year":"1985","unstructured":"Julkunen M, Rutanen EM, Koskimies A, Ranta T, Bohn H, Seppala M: Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol. 1985, 92 (11): 1145-1151. 10.1111\/j.1471-0528.1985.tb03027.x.","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"4251_CR13","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1095\/biolreprod.103.017830","volume":"69","author":"H Koistinen","year":"2003","unstructured":"Koistinen H, Easton RL, Chiu PC, Chalabi S, Halttunen M, Dell A, Morris HR, Yeung WS, Seppala M, Koistinen R: Differences in glycosylation and sperm-egg binding inhibition of pregnancy-related glycodelin. Biol Reprod. 2003, 69 (5): 1545-1551. 10.1095\/biolreprod.103.017830.","journal-title":"Biol Reprod"},{"issue":"2","key":"4251_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/molehr\/8.2.142","volume":"8","author":"JY Tse","year":"2002","unstructured":"Tse JY, Chiu PC, Lee KF, Seppala M, Koistinen H, Koistinen R, Yao YQ, Yeung WS: The synthesis and fate of glycodelin in human ovary during folliculogenesis. Mol Hum Reprod. 2002, 8 (2): 142-148. 10.1093\/molehr\/8.2.142.","journal-title":"Mol Hum Reprod"},{"issue":"8","key":"4251_CR15","doi-asserted-by":"publisher","first-page":"5378","DOI":"10.1074\/jbc.M607482200","volume":"282","author":"PC Chiu","year":"2007","unstructured":"Chiu PC, Chung MK, Koistinen R, Koistinen H, Seppala M, Ho PC, Ng EH, Lee KF, Yeung WS: Cumulus oophorus-associated glycodelin-C displaces sperm-bound glycodelin-A and -F and stimulates spermatozoa-zona pellucida binding. J Biol Chem. 2007, 282 (8): 5378-5388.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"4251_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.mce.2005.12.038","volume":"250","author":"WS Yeung","year":"2006","unstructured":"Yeung WS, Lee KF, Koistinen R, Koistinen H, Seppala M, Ho PC, Chiu PC: Roles of glycodelin in modulating sperm function. Mol Cell Endocrinol. 2006, 250 (1\u20132): 149-156.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"4251_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/humupd\/dmm004","volume":"13","author":"M Seppala","year":"2007","unstructured":"Seppala M, Koistinen H, Koistinen R, Chiu PC, Yeung WS: Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations. Hum Reprod Update. 2007, 13 (3): 275-287. 10.1093\/humupd\/dmm004.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"4251_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jri.2009.10.012","volume":"85","author":"U Jeschke","year":"2010","unstructured":"Jeschke U, Toth B, Scholz C, Friese K, Makrigiannakis A: Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss. J Reprod Immunol. 2010, 85 (1): 99-105. 10.1016\/j.jri.2009.10.012.","journal-title":"J Reprod Immunol"},{"issue":"1","key":"4251_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/cimm.1998.1408","volume":"191","author":"J Rachmilewitz","year":"1999","unstructured":"Rachmilewitz J, Riely GJ, Tykocinski ML: Placental protein 14 functions as a direct T-cell inhibitor. Cell Immunol. 1999, 191 (1): 26-33. 10.1006\/cimm.1998.1408.","journal-title":"Cell Immunol"},{"issue":"2","key":"4251_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0008-8749(03)00129-1","volume":"222","author":"E Yaniv","year":"2003","unstructured":"Yaniv E, Borovsky Z, Mishan-Eisenberg G, Rachmilewitz J: Placental protein 14 regulates selective B cell responses. Cell Immunol. 2003, 222 (2): 156-163. 10.1016\/S0008-8749(03)00129-1.","journal-title":"Cell Immunol"},{"issue":"16","key":"4251_CR21","doi-asserted-by":"publisher","first-page":"14059","DOI":"10.1074\/jbc.M211716200","volume":"278","author":"J Rachmilewitz","year":"2003","unstructured":"Rachmilewitz J, Borovsky Z, Riely GJ, Miller R, Tykocinski ML: Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45. J Biol Chem. 2003, 278 (16): 14059-14065. 10.1074\/jbc.M211716200.","journal-title":"J Biol Chem"},{"issue":"10","key":"4251_CR22","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1074\/jbc.M306673200","volume":"279","author":"D Mukhopadhyay","year":"2004","unstructured":"Mukhopadhyay D, SundarRaj S, Alok A, Karande AA: Glycodelin A, not glycodelin S, is apoptotically active. Relevance of sialic acid modification. J Biol Chem. 2004, 279 (10): 8577-8584. 10.1074\/jbc.M306673200.","journal-title":"J Biol Chem"},{"issue":"1","key":"4251_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/1756-0500-5-551","volume":"5","author":"C Scholz","year":"2012","unstructured":"Scholz C, Heublein S, Lenhard M, Friese K, Mayr D, Jeschke U: Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients. BMC Res Notes. 2012, 5 (1): 551-10.1186\/1756-0500-5-551.","journal-title":"BMC Res Notes"},{"issue":"6","key":"4251_CR24","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/j.ajog.2005.05.073","volume":"193","author":"H Koistinen","year":"2005","unstructured":"Koistinen H, Seppala M, Nagy B, Tapper J, Knuutila S, Koistinen R: Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells. Am J Obstet Gynecol. 2005, 193 (6): 1955-1960. 10.1016\/j.ajog.2005.05.073.","journal-title":"Am J Obstet Gynecol"},{"issue":"16","key":"4251_CR25","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.ejca.2007.08.014","volume":"43","author":"N Shabani","year":"2007","unstructured":"Shabani N, Kuhn C, Kunze S, Schulze S, Mayr D, Dian D, Gingelmaier A, Schindlbeck C, Willgeroth F, Sommer H, et al: Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. Eur J Cancer. 2007, 43 (16): 2434-2444. 10.1016\/j.ejca.2007.08.014.","journal-title":"Eur J Cancer"},{"issue":"4","key":"4251_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2559.2006.02351.x","volume":"48","author":"U Jeschke","year":"2006","unstructured":"Jeschke U, Kuhn C, Mylonas I, Schulze S, Friese K, Mayr D, Speer R, Briese V, Richter DU, Haase M, et al: Development and characterization of monoclonal antibodies for the immunohistochemical detection of glycodelin A in decidual, endometrial and gynaecological tumour tissues. Histopathology. 2006, 48 (4): 394-406. 10.1111\/j.1365-2559.2006.02351.x.","journal-title":"Histopathology"},{"issue":"5","key":"4251_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1369\/jhc.2008.950600","volume":"56","author":"B Toth","year":"2008","unstructured":"Toth B, Roth K, Kunert-Keil C, Scholz C, Schulze S, Mylonas I, Friese K, Jeschke U: Glycodelin protein and mRNA is downregulated in human first trimester abortion and partially upregulated in mole pregnancy. J Histochem Cytochem. 2008, 56 (5): 477-485. 10.1369\/jhc.2008.950600.","journal-title":"J Histochem Cytochem"},{"issue":"5","key":"4251_CR28","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.fertnstert.2006.03.062","volume":"86","author":"I Mylonas","year":"2006","unstructured":"Mylonas I, Jeschke U, Kunert-Keil C, Shabani N, Dian D, Bauerfeind I, Kuhn C, Kupka MS, Friese K: Glycodelin A is expressed differentially in normal human endometrial tissue throughout the menstrual cycle as assessed by immunohistochemistry and in situ hybridization. Fertil Steril. 2006, 86 (5): 1488-1497. 10.1016\/j.fertnstert.2006.03.062.","journal-title":"Fertil Steril"},{"issue":"2A","key":"4251_CR29","first-page":"1107","volume":"23","author":"C Bergemann","year":"2003","unstructured":"Bergemann C, Reimer T, Muller H, Hosel A, Briese V, Friese K, Jeschke U: Stimulation of hCG protein and mRNA levels in trophoblast tumour cells Jeg3 and BeWo by glycodelin A. Anticancer Res. 2003, 23 (2A): 1107-1113.","journal-title":"Anticancer Res"},{"issue":"5","key":"4251_CR30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00418-003-0529-0","volume":"119","author":"U Jeschke","year":"2003","unstructured":"Jeschke U, Wang X, Briese V, Friese K, Stahn R: Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion. Histochem Cell Biol. 2003, 119 (5): 345-354.","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"4251_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00418-008-0510-z","volume":"131","author":"U Jeschke","year":"2009","unstructured":"Jeschke U, Mylonas I, Kunert-Keil C, Stahn R, Scholz C, Janni W, Kuhn C, Schroder E, Mayr D, Friese K: Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer. Histochem Cell Biol. 2009, 131 (2): 283-295. 10.1007\/s00418-008-0510-z.","journal-title":"Histochem Cell Biol"},{"issue":"3A","key":"4251_CR32","first-page":"1581","volume":"25","author":"U Jeschke","year":"2005","unstructured":"Jeschke U, Bischof A, Speer R, Briese V, Richter DU, Bergemann C, Mylonas I, Shabani N, Friese K, Karsten U: Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors. Anticancer Res. 2005, 25 (3A): 1581-1589.","journal-title":"Anticancer Res"},{"issue":"1","key":"4251_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1677\/jme.0.0230057","volume":"23","author":"C Keil","year":"1999","unstructured":"Keil C, Husen B, Giebel J, Rune G, Walther R: Glycodelin mRNA is expressed in the genital tract of male and female rats (Rattus norvegicus). J Mol Endocrinol. 1999, 23 (1): 57-66. 10.1677\/jme.0.0230057.","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"4251_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00418-008-0533-5","volume":"131","author":"C Kunert-Keil","year":"2009","unstructured":"Kunert-Keil C, Jeschke U, Simms G, Kasper M: Increased expression of glycodelin mRNA and protein in rat lungs during ovalbumin-induced allergic airway inflammation. Histochem Cell Biol. 2009, 131 (3): 383-390. 10.1007\/s00418-008-0533-5.","journal-title":"Histochem Cell Biol"},{"issue":"3","key":"4251_CR35","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe. 1987, 8 (3): 138-140.","journal-title":"Pathologe"},{"issue":"1","key":"4251_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983, 15 (1): 10-17. 10.1016\/0090-8258(83)90111-7.","journal-title":"Gynecol Oncol"},{"issue":"3\u20134","key":"4251_CR37","first-page":"237","volume":"10","author":"L Deligdisch","year":"1987","unstructured":"Deligdisch L, Holinka CF: Endometrial carcinoma: two diseases?. Cancer Detect Prev. 1987, 10 (3\u20134): 237-246.","journal-title":"Cancer Detect Prev"},{"issue":"1","key":"4251_CR38","first-page":"S1","volume":"24","author":"WT Creasman","year":"1997","unstructured":"Creasman WT: Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment. Semin Oncol. 1997, 24 (1): S1-S140. S141-150","journal-title":"Semin Oncol"},{"issue":"2 Pt 1","key":"4251_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/AOG.0b013e3181954c5b","volume":"113","author":"S Kumar","year":"2009","unstructured":"Kumar S, Shah JP, Bryant CS, Seward S, Ali-Fehmi R, Morris RT, Malone JM: Radiation-associated endometrial cancer. Obstet Gynecol. 2009, 113 (2 Pt 1): 319-325.","journal-title":"Obstet Gynecol"},{"issue":"34\u201335","key":"4251_CR40","first-page":"571","volume":"108","author":"D Denschlag","year":"2010","unstructured":"Denschlag D, Ulrich U, Emons G: The diagnosis and treatment of endometrial cancer: progress and controversies. Dtsch Arztebl Int. 2010, 108 (34\u201335): 571-577.","journal-title":"Dtsch Arztebl Int"},{"key":"4251_CR41","volume-title":"Am J Clin Oncol","author":"Z Nicholas","year":"2012","unstructured":"Nicholas Z, Hu N, Ying J, Soisson P, Dodson M, Gaffney DK: Impact of comorbid conditions on survival in endometrial cancer. Am J Clin Oncol. 2012, [Epub ahead of print]"},{"issue":"5","key":"4251_CR42","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1210\/endo-118-5-1782","volume":"118","author":"M Julkunen","year":"1986","unstructured":"Julkunen M, Koistinen R, Sjoberg J, Rutanen EM, Wahlstrom T, Seppala M: Secretory endometrium synthesizes placental protein 14. Endocrinology. 1986, 118 (5): 1782-1786. 10.1210\/endo-118-5-1782.","journal-title":"Endocrinology"},{"issue":"5","key":"4251_CR43","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1210\/mend-4-5-700","volume":"4","author":"M Julkunen","year":"1990","unstructured":"Julkunen M, Koistinen R, Suikkari AM, Seppala M, Janne OA: Identification by hybridization histochemistry of human endometrial cells expressing mRNAs encoding a uterine beta-lactoglobulin homologue and insulin-like growth factor-binding protein-1. Mol Endocrinol. 1990, 4 (5): 700-707. 10.1210\/mend-4-5-700.","journal-title":"Mol Endocrinol"},{"issue":"10","key":"4251_CR44","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1002\/ijc.23773","volume":"123","author":"LC Hautala","year":"2008","unstructured":"Hautala LC, Koistinen R, Seppala M, Butzow R, Stenman UH, Laakkonen P, Koistinen H: Glycodelin reduces breast cancer xenograft growth in vivo. Int J Cancer. 2008, 123 (10): 2279-2284. 10.1002\/ijc.23773.","journal-title":"Int J Cancer"},{"issue":"3","key":"4251_CR45","first-page":"413","volume":"13","author":"U Jeschke","year":"2005","unstructured":"Jeschke U, Mylonas I, Kunert-Keil C, Dazert E, Shabani N, Werling M, Kuhn C, Janni W, Gerber B, Friese K: Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Oncol Rep. 2005, 13 (3): 413-419.","journal-title":"Oncol Rep"},{"issue":"19","key":"4251_CR46","first-page":"6258","volume":"63","author":"E Mandelin","year":"2003","unstructured":"Mandelin E, Lassus H, Seppala M, Leminen A, Gustafsson JA, Cheng G, Butzow R, Koistinen R: Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res. 2003, 63 (19): 6258-6264.","journal-title":"Cancer Res"},{"issue":"12","key":"4251_CR47","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1200\/JCO.2008.19.0694","volume":"27","author":"E Galanis","year":"2009","unstructured":"Galanis E, Jaeckle KA, Maurer MJ, Reid JM, Ames MM, Hardwick JS, Reilly JF, Loboda A, Nebozhyn M, Fantin VR, et al: Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study. J Clin Oncol. 2009, 27 (12): 2052-2058. 10.1200\/JCO.2008.19.0694.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4251_CR48","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/JTO.0b013e3181952478","volume":"4","author":"AM Traynor","year":"2009","unstructured":"Traynor AM, Dubey S, Eickhoff JC, Kolesar JM, Schell K, Huie MS, Groteluschen DL, Marcotte SM, Hallahan CM, Weeks HR, et al: Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study. J Thorac Oncol. 2009, 4 (4): 522-526. 10.1097\/JTO.0b013e3181952478.","journal-title":"J Thorac Oncol"},{"issue":"18","key":"4251_CR49","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1200\/JCO.2011.38.3265","volume":"30","author":"G Garcia-Manero","year":"2012","unstructured":"Garcia-Manero G, Tambaro FP, Bekele NB, Yang H, Ravandi F, Jabbour E, Borthakur G, Kadia TM, Konopleva MY, Faderl S, et al: Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome. J Clin Oncol. 2012, 30 (18): 2204-2210. 10.1200\/JCO.2011.38.3265.","journal-title":"J Clin Oncol"},{"issue":"12","key":"4251_CR50","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1210\/en.2005-0359","volume":"146","author":"H Uchida","year":"2005","unstructured":"Uchida H, Maruyama T, Nagashima T, Asada H, Yoshimura Y: Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology. 2005, 146 (12): 5365-5373. 10.1210\/en.2005-0359.","journal-title":"Endocrinology"},{"issue":"2","key":"4251_CR51","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1210\/en.2006-0896","volume":"148","author":"H Uchida","year":"2007","unstructured":"Uchida H, Maruyama T, Ono M, Ohta K, Kajitani T, Masuda H, Nagashima T, Arase T, Asada H, Yoshimura Y: Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology. 2007, 148 (2): 896-902. 10.1210\/en.2006-0896.","journal-title":"Endocrinology"},{"issue":"10","key":"4251_CR52","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1093\/humrep\/dem263","volume":"22","author":"H Uchida","year":"2007","unstructured":"Uchida H, Maruyama T, Ohta K, Ono M, Arase T, Kagami M, Oda H, Kajitani T, Asada H, Yoshimura Y: Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation. Hum Reprod. 2007, 22 (10): 2615-2622. 10.1093\/humrep\/dem263.","journal-title":"Hum Reprod"},{"issue":"1","key":"4251_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10549-010-1065-y","volume":"128","author":"LC Hautala","year":"2011","unstructured":"Hautala LC, Greco D, Koistinen R, Heikkinen T, Heikkila P, Aittomaki K, Blomqvist C, Koistinen H, Nevanlinna H: Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1\/2 breast cancer patients. Breast Cancer Res Treat. 2011, 128 (1): 85-95. 10.1007\/s10549-010-1065-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"41","key":"4251_CR54","doi-asserted-by":"publisher","first-page":"24116","DOI":"10.1074\/jbc.270.41.24116","volume":"270","author":"A Dell","year":"1995","unstructured":"Dell A, Morris HR, Easton RL, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M, Clark GF: Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem. 1995, 270 (41): 24116-24126. 10.1074\/jbc.270.41.24116.","journal-title":"J Biol Chem"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-616.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-616\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T07:25:49Z","timestamp":1716362749000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4251"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-616","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]},"article-number":"616"}}